Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theodor Klotz

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Urologie (Heidelberg, Germany)|June 24, 2026
[Beyond the bladder-a specialty rediscovering itself: Outpatient. Networked. Digital]Theodor Klotz, Bernhard Ralla
Asian Journal of Andrology|December 26, 2006
Improved spontaneous erectile function in men with mild-to-moderate arteriogenic erectile dysfunction treated with a nightly dose of sildenafil for one year: a randomized trialFrank Sommer, Theodor Klotz, Udo Engelmann
The Journal of Sexual Medicine|November 8, 2006
Patients responding to phosphodiesterase type 5 inhibitor therapy: what do their sexual partners know?Theodor Klotz, Mike Mathers, Rosemarie Klotz, et al.
European Urology|December 13, 2006
The economic costs of overactive bladder in GermanyTheodor Klotz, Bernd Brüggenjürgen, Martin Burkart, et al.
Onkologie|July 29, 2006
Merkel cell carcinoma -- a rarity in the urogenital tractBernhard Schwindl, Andreas Meissner, Josef Giedl, et al.
Asian Journal of Andrology|February 24, 2006
Evaluation of tetrahydrobiopterin (BH4) as a potential therapeutic agent to treat erectile dysfunctionFrank Sommer, Theodor Klotz, Dirk Steinritz, et al.
European Urology|June 21, 2002
Cycling and penile oxygen pressure: the type of saddle mattersUlrich Schwarzer, Frank Sommer, Theodor Klotz, et al.
World Journal of Urology|September 17, 2015
HAROW: the first comprehensive prospective observational study comparing treatment options in localized prostate cancerLothar Weissbach, Steffen Stuerzebecher, Eberhard Mumperow, et al.
BJU International|January 15, 2008
Long-term treatment of erectile dysfunction with a phosphodiesterase-5 inhibitor and dose optimization based on nocturnal penile tumescenceMichael J Mathers, Theodor Klotz, Alexander S Brandt, et al.
BJU International|January 11, 2005
Differential endostatin binding to bladder, prostate and kidney tumour vesselsAnnette Schmidt, Frank Sommer, Michael Reiner, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Urologie (Heidelberg, Germany)|June 24, 2026
[Beyond the bladder-a specialty rediscovering itself: Outpatient. Networked. Digital]Theodor Klotz, Bernhard Ralla
Asian Journal of Andrology|December 26, 2006
Improved spontaneous erectile function in men with mild-to-moderate arteriogenic erectile dysfunction treated with a nightly dose of sildenafil for one year: a randomized trialFrank Sommer, Theodor Klotz, Udo Engelmann
The Journal of Sexual Medicine|November 8, 2006
Patients responding to phosphodiesterase type 5 inhibitor therapy: what do their sexual partners know?Theodor Klotz, Mike Mathers, Rosemarie Klotz, et al.
European Urology|December 13, 2006
The economic costs of overactive bladder in GermanyTheodor Klotz, Bernd Brüggenjürgen, Martin Burkart, et al.
Onkologie|July 29, 2006
Merkel cell carcinoma -- a rarity in the urogenital tractBernhard Schwindl, Andreas Meissner, Josef Giedl, et al.
Asian Journal of Andrology|February 24, 2006
Evaluation of tetrahydrobiopterin (BH4) as a potential therapeutic agent to treat erectile dysfunctionFrank Sommer, Theodor Klotz, Dirk Steinritz, et al.
European Urology|June 21, 2002
Cycling and penile oxygen pressure: the type of saddle mattersUlrich Schwarzer, Frank Sommer, Theodor Klotz, et al.
World Journal of Urology|September 17, 2015
HAROW: the first comprehensive prospective observational study comparing treatment options in localized prostate cancerLothar Weissbach, Steffen Stuerzebecher, Eberhard Mumperow, et al.
BJU International|January 15, 2008
Long-term treatment of erectile dysfunction with a phosphodiesterase-5 inhibitor and dose optimization based on nocturnal penile tumescenceMichael J Mathers, Theodor Klotz, Alexander S Brandt, et al.
BJU International|January 11, 2005
Differential endostatin binding to bladder, prostate and kidney tumour vesselsAnnette Schmidt, Frank Sommer, Michael Reiner, et al.
Pageof 3